[Symptomatic common bile duct lithiasis: endoscopic treatment or surgical treatment?].

Abstract

Since 1974, endoscopic sphincterotomy (ES) has been considered by most practitioners as the gold standard for the treatment of symptomatic common bile duct lithiasis (CBDL). Results of the seven prospectives randomized controlled trials comparing ES to surgery in the treatment of CBDL, acute pancreatitis and angiocholitis excluded, demonstrated that: 1) the rate of feasibility of ES ranged from 90 to 100%; 2) the rate of residual stones after first extraction attempt ranged from 4 to 23% and after second extraction attempt from 6 to 25%. After surgery, rate of residual stone ranged from 2 to 14%; 3) major complications were more frequent after ES than after surgery; on the opposite, minor complications were more frequent after surgery than after ES; 4) immediate mortality was higher after ES than after surgery; 5) cost of ES with or without de principle cholecystectomy was higher than surgery. In conclusion ES should not be the first treatment of symptomatic CBDL.

• Authors: J M Hay
• Journal: Journal de chirurgie (J Chir (Paris)) Vol. 135 Issue 1 Pg. 4-9 (Feb 1998) ISSN: 0021-7697 [Print] France
• Vernacular Title: Lithiase de la voie biliaire principale symptomatique: traitement endoscopique ou traitement chirurgical?
• PMID: 9773004 (Publication Type: English Abstract, Journal Article, Review)

Topics

• Cholecystectomy
• Gallstones (surgery)
• Humans
• Laparotomy (adverse effects, economics, mortality)
• Patient Selection
• Prospective Studies
• Randomized Controlled Trials as Topic
• Sphincterotomy, Endoscopic (adverse effects, economics, mortality)
• Treatment Outcome